171 related articles for article (PubMed ID: 34582665)
1. Frequency of Hepatitis B Virus infection among Patients before Chemotherapy Treatment.
Mahmoudvand S; Shokri S; Mirzaei H; Ramazani A; Makvandi M; Neisi N; Hashemi SJ
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2939-2944. PubMed ID: 34582665
[TBL] [Abstract][Full Text] [Related]
2. Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.
Elkady A; Aboulfotuh S; Ali EM; Sayed D; Abdel-Aziz NM; Ali AM; Murakami S; Iijima S; Tanaka Y
World J Gastroenterol; 2013 Oct; 19(37):6214-20. PubMed ID: 24115819
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Hepatitis B Markers in Systemic Lupus Erythematosus Patients in Iran.
Makvandi M; Noormandi Pour S; Teimoori A; Shokri S; Mahmoudvand S; Biparva Haghighi S; Rajaee E
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1921-1926. PubMed ID: 35763632
[TBL] [Abstract][Full Text] [Related]
4. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
[TBL] [Abstract][Full Text] [Related]
6. Occult hepatitis B virus infection in hemodialysis patients in Recife, State of Pernambuco, Brazil.
Albuquerque AC; Coelho MR; Lemos MF; Moreira RC
Rev Soc Bras Med Trop; 2012 Oct; 45(5):558-62. PubMed ID: 23152336
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects.
Azarkar Z; Ziaee M; Ebrahimzadeh A; Sharifzadeh G; Javanmard D
J Med Virol; 2019 Apr; 91(4):615-622. PubMed ID: 30345529
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B infection among individuals belonging to the aboriginal Nicobarese tribe of India.
Bhattacharya H; Bhattacharya D; Roy S; Sugunan AP
J Infect Dev Ctries; 2014 Dec; 8(12):1630-5. PubMed ID: 25500663
[TBL] [Abstract][Full Text] [Related]
10. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
13. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
[TBL] [Abstract][Full Text] [Related]
14. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.
El-Sherif A; Abou-Shady M; Abou-Zeid H; Elwassief A; Elbahrawy A; Ueda Y; Chiba T; Hosney AM
J Gastroenterol; 2009; 44(4):359-64. PubMed ID: 19271112
[TBL] [Abstract][Full Text] [Related]
15. Anti-HBc and hepatitis B virus DNA among HBsAg-negative blood donors from the main central blood bank units in Eastern Libya.
El-Nabi SH; El-Garawani I; Ismail F; Abdelsameea E
Transfus Med; 2020 Oct; 30(5):401-405. PubMed ID: 32894893
[TBL] [Abstract][Full Text] [Related]
16. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients.
Arababadi MK; Pourfathollah AA; Jafarzadeh A; Hassanshahi G; Rezvani ME
J Gastroenterol Hepatol; 2010 Jan; 25(1):90-3. PubMed ID: 19793172
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
[TBL] [Abstract][Full Text] [Related]
18. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview.
Mandour M; Nemr N; Shehata A; Kishk R; Badran D; Hawass N
Rev Soc Bras Med Trop; 2015; 48(3):258-64. PubMed ID: 26108002
[TBL] [Abstract][Full Text] [Related]
19. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen.
Hennig H; Puchta I; Luhm J; Schlenke P; Goerg S; Kirchner H
Blood; 2002 Oct; 100(7):2637-41. PubMed ID: 12239179
[TBL] [Abstract][Full Text] [Related]
20. Update on occult hepatitis B virus infection.
Makvandi M
World J Gastroenterol; 2016 Oct; 22(39):8720-8734. PubMed ID: 27818588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
